Weiss Multi-Strategy Advisers’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,750	Closed	-$348K	–	539
2016 Q3	$348K	Sell	1,750 -73	-4%	-$12.6K	0.02%	364
2016 Q2	$236K	Sell	1,823 -1,177	-39%	-$131K	0.02%	367
2016 Q1	$281K	Buy	3,000 +450	+18%	+$49K	0.01%	414
2015 Q4	$517K	Buy	2,550 +500	+24%	+$89.4K	0.04%	302
2015 Q3	$298K	Buy	+2,050	New	+$376K	0.01%	353
2015 Q2	–	Sell	-5,000	Closed	-$1.16M	–	549
2015 Q1	$1.16M	Hold	5,000	–	–	0.05%	307
2014 Q4	$1.15M	Buy	+5,000	New	+$1.07M	0.04%	266

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Weiss Multi-Strategy Advisers's BLCM Position: Q4 2016 in Review

Weiss Multi-Strategy Advisers sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2016, closing a stake of 1,750 shares — an estimated $348K sold.

Weiss Multi-Strategy Advisers first reported a position in BLCM in Q4 2014 and held it in 7 quarters. The position peaked at $1.16M in Q1 2015. 80 funds tracked by Wall St. Rank hold BLCM as of Q4 2016.

Weiss Multi-Strategy Advisers reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 1,750 Bellicum Pharmaceuticals, Inc. shares in Q4 2016, an estimated $348K.
Weiss Multi-Strategy Advisers first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 7 quarters.
Weiss Multi-Strategy Advisers's Bellicum Pharmaceuticals, Inc. position peaked at $1.16M in Q1 2015.
80 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2016.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2016, filed 14 Feb 2017.